Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Daiichi Sankyo Ltd ADR (OP:DSNKY)

21.94 -0.20 (-0.90%)
Streaming Delayed Price Updated: 3:59 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 187,884
Open 22.00
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 22.14
Today's Range 21.75 - 22.00
52wk Range 20.92 - 33.21
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
FDA Approves AstraZeneca And Daiichi Sankyo's Datroway For EGFR-Mutated Lung Cancer
FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response rate and a $45 million milestone due. 
Via Benzinga

Performance

YTD
-19.6%
-19.6%
1 Month
-17.7%
-17.7%
3 Month
-10.1%
-10.1%
6 Month
-10.1%
-10.1%
1 Year
-31.6%
-31.6%

More News

Read More
AstraZeneca- Daiichi Sankyo's Multi-Billion Dollar Cancer Drug Shows Superior Efficacy Across Broad HER2 Positive Metastatic Breast Cancer Patients
Via Benzinga
DSNKY Stock Earnings: Daiichi Sankyo Co Reported Results for Q1 2024
Via InvestorPlace
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
Via Benzinga
FDA Approves AstraZeneca, Daiichi Sankyo's Enhertu For Certain Type Of Breast Cancer Patients
Via Benzinga
FDA Approves AstraZeneca's Datroway For Pretreated Breast Cancer Patients
Via Benzinga
After Lung Cancer Approval, AstraZeneca's Imfinzi Goes Under FDA Priority Review For Bladder Cancer
Via Benzinga
Latest Trial Setback For AstraZeneca's Dato-DXd, The Drug Fails To Extend Lives Of Pretreated Breast Cancer Patients
Via Benzinga
Merck/Daiichi Sankyo Partnered Lung Cancer Candidate Meets Primary Goal In Late-Stage Study
Via Benzinga
AstraZeneca's Investigational Cancer Drug Disappoints In Late-Stage Lung Cancer Trial
Via Benzinga
Is Merck Stock Undervalued After Its Colossal Earnings Growth?
Via MarketBeat
Recession-Resilient Asian Stock Picks: TSMC, SK Hynix Among This Analyst's Top 10
Via Benzinga
Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual Profit Forecast
Via Benzinga
The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024
Via InvestorPlace
FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug
Via Benzinga
Why Is AstraZeneca Stock Trading Lower On Tuesday?
Via Benzinga
DSNKY Stock Earnings: Daiichi Sankyo Co Reported Results for Q3 2023
Via InvestorPlace
Double Good News For AstraZeneca's Breast Cancer Drugs
Via Benzinga
AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor
Via Benzinga
What's Going On With Pfizer Stock Today?
Via Benzinga
Why Pharmaceutical Company Esperion Therapeutics Shares Are Diving Today
Via Benzinga
Japan Emerges As Promising 2024 Investment Destination: 3 Stocks To Consider
Via Benzinga
Merck Just Made a Big Move -- but Will It Be Enough for Investors Right Now?
Via The Motley Fool
Better Than Chemotherapy - AstraZeneca/Daiichi Sankyo Partnered Cancer Drug Meets Primary Goal In Breast Cancer Setting
Via Benzinga

Frequently Asked Questions

Is Daiichi Sankyo Ltd ADR publicly traded?
Yes, Daiichi Sankyo Ltd ADR is publicly traded.
What exchange does Daiichi Sankyo Ltd ADR trade on?
Daiichi Sankyo Ltd ADR trades on the OTC Traded
What is the ticker symbol for Daiichi Sankyo Ltd ADR?
The ticker symbol for Daiichi Sankyo Ltd ADR is DSNKY on the OTC Traded
What is the current price of Daiichi Sankyo Ltd ADR?
The current price of Daiichi Sankyo Ltd ADR is 21.94
When was Daiichi Sankyo Ltd ADR last traded?
The last trade of Daiichi Sankyo Ltd ADR was at 11/07/25 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.